AVALO THERAPEUTICS, INC. Operating Lease, Liability, Current
AVALO THERAPEUTICS, INC. (AVTX) had Operating Lease, Liability, Current of $242.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $242.00K.
- 2026-03-31: Operating Lease, Liability, Current $328.00K.
- 2025-12-31: Operating Lease, Liability, Current $392.00K.
- 2025-09-30: Operating Lease, Liability, Current $438.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $242.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $328.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $392.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $438.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $482.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $526.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $568.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $550.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $548.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $545.00K 10-Q/A · filed 2024-07-11 | |
| 2023-12-31 | $537.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $536.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $535.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $533.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $532.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $526.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $524.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $522.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $485.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $219.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $288.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $357.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $426.00K 10-K · filed 2022-03-02 | $426.35K 10-K · filed 2021-03-08 |
| 2020-09-30 | $448.66K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $431.54K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $166.40K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $155.81K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $114.39K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |